Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

One cancer patient says he probably wouldn’t be here today if it weren’t for getting the test after he was diagnosed with ...

Lainie Jones has Li-Fraumeni syndrome, which makes her predisposed to having cancer. She's undergoing treatment for ...

Dr. Bansal and Staff Sandeep Bansal, MD, FCCP, FACP, Medical Director of The Lung Center and Interventional Pulmonology at ...

Artificial intelligence (AI) can greatly help in this direction, as evidenced by a partnership between the pharmaceutical giant AstraZeneca and Qure.ai. Through its AI-powered tool, qXR, this ...

Cancer survivors want to see more access to screenings that they call "a game changer." It's called biomarker testing, which analyzes a patient's tissue, blood or other bodily fluids to help pinpoint ...

The main reason that it is so deadly is that symptoms are not obvious in the early stages, which is why it's sometimes ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

Lung cancer in never-smokers is estimated to be the fifth leading cause of cancer-related mortality worldwide. A World Cancer ...